The United States Securities and Exchange Commission (SEC) has announced the effectiveness of a Form S-3 for iBio, Inc. The notice, issued from Washington, D.C., indicates that the form became effective on August 6, 2024, at 4:00 P.M. This form is typically used by companies to register securities for potential future offerings. The SEC's notice confirms that iBio, Inc., which is listed under the Central Index Key (CIK) number 0001420720 and has the file number 333-280680, has met the requirements for this registration statement to become effective.

The United States Securities and Exchange Commission (SEC) has announced the effectiveness of a Form S-3 for iBio, Inc. The notice, issued from Washington, D.C., indicates that the form became effective on August 6, 2024, at 4:00 P.M. This form is typically used by companies to register securities for potential future offerings. The SEC's notice confirms that iBio, Inc., which is listed under the Central Index Key (CIK) number 0001420720 and has the file number 333-280680, has met the requirements for this registration statement to become effective.